A bstract M utations o f th e B ru to n 's tyrosine kinase (Btk) gene cause X linked agam m aglobu lin aem ia (XLA). T his in h erited im m u n od eficien cy d isease cau ses an arrest in B cell differentiation o f p re-B cells to m a ture B cells, in th is study w e report the ch aracterisation o f m utations in the
Keywords: X linked agammaglobulinaemia; Bruton's tyrosine kinase; immunodeficiency X linked agammaglobulinaemia (XLA) was the first disorder of hum oral immunity to be described as early as 1952 by B ruton.1 This inherited immunodeficiency is characterised by protracted and recurrent bacterial infec tions. Affected males have severely decreased numbers of circulating mature B lymphocytes and show a lack of all immunoglobulin (Ig) isotypes.2 In the bone marrow the num ber of B lymphocyte precursors, identified by Ig heavy chain expression in the cytoplasm, are normal or decreased. Therefore, XLA reflects an arrest in differentiation of pre-B cells to later B cell stages.3 The cellular defect is limited to the B cell line, since female XLA carriers manifest a unilateral X chromosome inactivation in the peripheral blood B cell population.4 The disor der is usually diagnosed quite early in life and treatment consists of a lifetime of regular Ig infusions. In 1993 the causative gene in XLA was identified as a cytoplasmatic protein tyrosine kinase, named Bruton's tyrosine ki nase (Btk).5 6 This gene has been mapped to Xq21.3-Xq227 and is widely expressed throughout haematopoietic cell lines, including nearly all stages of B cell development, but is found at negligible levels in T cells and is downregulated in plasma cells.8 The 37.5 kb Btk locus contains 19 exons, 18 of which code for a 77 kDa protein. 9 Btk belongs to a subfamily of Src related cytoplasmatic protein tyrosine kinases (PTKs), including Tec II,10 Bmx,11 Txlc,12 Itk,13 and Dsrc 28C,14 also known as the Tec family. Proteins of the Tec family consist of five distinct structural domains, a unique N-terminal region, which is comprised of a pleckstrin homology (PH) domain13 and a Tec homology (TH) domain, 16 followed by Src homology (SH) 3, SH2, and catalytic (SHI) domains. PH domains have been found in a number of proteins involved in intracellular signalling pathways. Protein ki nase C and heterotrimeric G protein have been proposed to bind to the Btk PH domain.17 18 The T H domain contains two proline rich regions which have been shown to interact with the SH3 domains of Src protein tyrosine kinases Fyn, Lyn, and Hck.19 Analysis of Src family tyrosine kinases suggests that SH2 and SH3 domains are involved in intermolecular recognition and the formation of heterodimeric protein complexes. SH2 domains directly recognise phosphorylated tyrosine residues and the SH3 domain is implicated in die regu lation of protein-protein interactions via recog nition of specific proline rich peptide sequences.20 Signal transduction pathways are likely to be controlled by the formation of these protein complexes. 21 In general, the study of null mutations in a gene tiiat results in an inherited disorder will provide information about the functionally important domains of the gene product. In the 23 The first mutation data that were reported suggested that the severity of the XLA phenotype is dependent upon die site and nature of the m utation.9 24 25 Now that data on so many XLA patients have been reported, it has become evident that there is no strict correlation between the site of the mutation and the severity of the clinical and immunological expression of the disease* im plying that odier factors might determine the phenotype as well. This study was undertaken to analyse 14 subjects from 10 unrelated families who repre sent either familial or sporadic cases of XLA, based on a clinical and immunological diagno sis. Here we report the characterisation of mutations found in the Btk gene of these sub jects.
M aterials and m ethods

PATIENTS
Fourteen Dutch patients from 10 unrelated families were included in the study. All patients were male, aged between 2 and 38 years, and diagnosed as having XLA. The diagnosis of XLA was based on the absence or very low lev els of B cells in the circulation* low levels of immunoglobulins, and a history of recurrent bacterial infections.
RNA AND DNA ISOLATION PBMCs were prepared from fresh blood by Ficoll (Pharmacia) separation. RNA was ex tracted from the PBM C fraction with RNAzol B(Cinna/Biotex) and used for first strand cDNA synthesis with AMV reverse tran scriptase and iSforI-d(T) l8 primer. Genomic DNA was purified with a QIAgen isolation kit according to the m anufacturer's instructions.
PCR AMPLIFICATION
PCR amplification was carried out in four overlapping sections using the oligonucleotide primer sets listed in table 1 , P C R reactions were performed in a total volume of 100 p.1, consisting of 3 ¡llI cDNA, 50 mmol/1 KC1, 10 mmol/1 Tris-HCl, pH 8.4, 2 mmol/1 M gCl2, 50 pmol of each primer, 0.4 mmol/1 dN TPs, and 1 U AmpliTaq (Perkin-Elmer). Amplification was for 35 cycles with denaturation at 94°C, annealing at 60°C, and extension at 72°C, each for 30 seconds on a Perldn-Elmer Thermal Cycler system 9600.
Genomic D N A PC R amplification was carried out with the sets of primers flanking all j exons as reported by Vorechovsky et al*' using their cycling protocol with some modifications, SEQUENCE ANALYSIS Preamplified P C R products were used as tem plates for direct cycle sequence kit (Perkin-Elmer) according to the m anufacturer's in structions.
PCR-SSCP PC R products for single strand conformation polymorphism (SSCP) were generated accord ing the same protocol as described above. The detection of SSCPs was carried out on non-denaturating agarose gels on the PhastSystem T M (Pharmacia,Sweden). After dilution 1:1 in formamide loading buffer, die amplifica tion products were loaded onto 20% homoge neous phastgels (Pharmacia). Electrophoresis was done at 15°C at 250 Vh. D NA was visual ised by silver staining according to the instruc tions of the manufacturer.
R esults
MUTATION ANALYSIS OF THE BTK GENE
Characterisation of mutations in the Btk gene of XLA patients was carried out by using the following strategy. To identify mutations in the coding region of Btk, cDNA was prepared by a reverse transcriptase PC R reaction from pe ripheral blood mononuclear cells. The ampli fied products encompassed the coding se quence in four overlapping segments. T he PC R product of each segment was directly se quenced by cycle sequencing. To analyse and confirm the identified mutations in patient cDNA, we amplified and sequenced patient genomic D NA witii primers flanking the exon involved. M utation analysis was performed in a total of 14 subjects from 10 unrelated families of D utch origin. Patients were diagnosed as classical XLA based upon the num ber of peripheral B cells and serum Ig levels. In four families there were two male members affected with X linked immunodeficiency disease; die other patients were sporadic cases. All patients analysed showed alterations in the Btk gene, which are summarised in table 2, Various mutations were observed, including insertions, deletions, and missense or nonsense mutations. Five patients manifested single point mutations in the coding sequence. Patient 6 showed a T ->C change at position 164 replacing the hydrophobic non-polar amino acid leucine with another hydrophobic non-polar amino acid proline, at residue 1 1 in the P H domain. T he L eu l 1 amino acid is strongly conserved in residues that form the first p sheet of known P H domain sequences, like pleckstrin, spectrin, and dynamin. 27 In patient 4, a T -»G sub stitution was found at position 1218 tiiat 4 8 5 486 Brooimam et al from an amino acid asparagine for an aromatic tyrosine. This residue seems not to be directly involved in phosphotyrosyl peptide binding, but the effect of the mutation might be structural. In patient 7, a mutation C->T at position 895 was identified which results in a premature termination signal at amino acid residue 255. This mutation has also been described in two other unrelated XLA patients.29 30 Patient 8 had a C^T nonsense mutation at position 1114, giving rise to a pre mature stop codon at amino acid residue 308 in the SH2 domain of Btk.
In four patients, abnormal sized Btk tran scripts were found, which were the result of aberrant splicing. Fig 1A shows a schematic representation of the effects of splicing muta tions in these patients. The larger deletions and insertions had already been observed by size analysis of the four cDNA segments in comparison with normal sized PCR products. The PCR product obtained with primers Btk B F and Btk B R was smaller in patient 2 (391 bp) than the control (527 bp) ( fig IB) . Sequence analysis of the smaller fragment showed that the transcript lacked nucleotides 773 to 908 ( fig 1C ) . According to the location of the dele tion or insertion in the transcript, the appropri ate exon-intron boundaries were sequenced using genomic DNA from the patient as template. The observed deletion in patient 2 is compatible with a cryptic donor splice site present within exon 8, other relatives had inherited the same defective gene. This was done by using SSCP analysis with primer combinations flanking the exons involved.26 SSCP analysis of exon 12 from the relatives of patient 4, shown in fig 2, indicated that the mother of the affected boy and his sis ter were carriers. SSCP analysis was also performed for screening of the carrier status of female relatives of patients in family 2, 3, 6, and 10 (data not shown).
D iscussion
In this study we have identified the mutations in the Btk gene of 14 p atients from 10 unrelated families with a classical XLA pheno type. Mutation analysis performed in all patients, who were selected on the basis of recurrent infections or B cell levels of less than 1 %, identified a mutation in the coding region of the Btk gene. The identified mutations were submitted to the Btk mutation database that has been established by Vihinen et aZ. 31 All but one of these mutations differed from previously reported mutations in the BTK gene and are all spread throughout the gene. The mutation analysis approach that was chosen was based upon first screening patients5 cDNA and confirming the detected mutation on genomic DNA templates, especially to identify those mutations in which aberrant splicing is in volved. Others have shown that PCR-SSCP analysis is useful in screening for new muta tions in XLA patients.25 26 32 However, because of the genomic organisation of 19 exons which encompasses the entire Btk gene, one has to use 20 to 25 primer pairs for this analysis. From a cost effectiveness point of view we decided to use the PCR-SSCP analysis only for screening of carriers. To date, in more than 200 unrelated XLA patients, mutations scattered all along the Btk gene have been identified.22 23 In this study three patients out of a total of 14 had a missense mutation. Patient 6 had a single amino acid substitution that is a conserved residue of the first (5 sheet of the PH domain. Several other missense mutations have been described located in this PH domain. Based on the three dimensional structure of the Btk PH domain these mutated residues could form a binding site, since most of them were located close to each other on the surface of the molecule, suggesting that this domain is involved in protein-protein interactions.27 33 For instance, Btk PH domains have been shown to interact with protein kinase C. 17 The other two observed missense mutations were localised in the SH2 domain of Btk. Alignment between this domain and SH 2 of v-Src indicated that the m utated residue 362 is directly involved in binding to phosphotyrosyl peptides. 28 Most of the other identified mutations caused rearranged Btk transcripts or premature termination signals or both, encoding at best a truncated protein lacking the complete or functional part of the kinase domain. All of these patients showed the typical XLA pheno type with recurrent infections, B cell numbers less than 1%, and low serum Ig levels. The splice mutation detected in XLA patient 1 1 did not occur in the absolutely conserved position of the donor splice junction,34 leaving the possibility that some norm al Btk transcript is produced. On agarose gels no normal sized PC R product was detectable (data not shown). Furtherm ore it has been shown by others that several mutations at this position abolish normal splicing and result in similar rearrangements,35"37 From various reports it has become clear that it is very difficult to correlate the nature of a m utation with the severity of the disease. There have been m utations found causing premature stop codons and frame shifts affecting essential domains of Btk in patients with clinically mild phenotypes.25 Even between individual patients within one family with the same genotype, discordant phenotypes can o c c u r.F u rth e rm o re , a recent study has shown that the majority of identified muta tions, including missense m utations, lead to no detectable protein kinase activity. 39 This sug gests that these m utations could have different effects on mRNA and protein stability, XLA carriers cannot be distinguished pheno typically from norm al subjects. However, by SSCP analysis it is possible to detect an XLA carrier by determining the presence of a normal band and an altered band identical to that of the patient, Four families were sub jected to carrier analysis. Using PC R-SSC P we could successfully identify the carriers among family members (fig 2) . This technique enables quick screening of relatives of the patient whether they have inherited the same defective gene or not and can also be used for prenatal diagnosis.
So far, a large am ount of data have been obtained on m utation analysis of the Btk gene in typical XLA patients and screening methods have become more efficient for analysis of patients. It would be preferable to include more subjects with atypical disease in these Btk mutation analysis studies, such as, for instance, patients diagnosed as having com m on variable immunodeficiency diseases (CVID), since there are examples of an affected Btk gene in some of these patients. 40 In general, one can conclude that three years after the identification of the causative gene responsible for XLA., the function of Btk in B cell differentiation still remains to be clarified. To date it is evident that there is no direct cor relation between genotype and the clinical expression of the XLA phenotype, indicating that several other factors could play a role in the obs erved heterogeneity in X LA . For instance, genetic factors might influence the severity of the phenotype or past infections might play a role. Targeted deletion studies in mice have shown that the lack of Btk leads to impaired expression of B cell progenitors.'1142 However., mature B cells are expressed in these mice3 but show defective responses to thymus independent type II antigens^ indicating a similar Xid phenotype to that observed in the CBA/N m ice. 13 44 It seems that the difficulty in explaining the observed heterogeneity differ ences in m an and mice is correlated with the lack of knowledge concerning the functional role of the Btk protein. For a better under standing of the pathogenesis of XLA3 it is therefore essential to study the expressed func tional Btk protein, including determination of substrates of Btk in the B cell and the proteins that interact with the Btk gene product.
